EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma

Ariana N Jacobs, Dominique Jahn, Tim Beringer, Sebastian Wolf, Ramesh K Krishnan, Michael Engelke, Björn Häupl, Silvia Münch, Niklas Dienstbier, Martine Pape, Marion Bodach, Xin Yu und 8 weitere

Proceedings of the National Academy of Sciences · 03.02.2026 · 123 (5)

DOI: 10.1073/pnas.2534531123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 27.01.2026. Verfasst von Ariana N Jacobs und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 2, Hematology/Oncology, University Medical Center Frankfurt, Goethe University, Frankfurt am Main 60590, Germany. Hauptthemen laut MEDLINE: rhoA GTP-Binding Protein, Signal Transduction, Receptors, Antigen, B-Cell, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LOEWE Hessen, Deutsche Forschungsgemeinschaft (DFG), Else Kröner-Fresenius-Stiftung (EKFS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B cell lymphoma (DLBCL) is characterized by a variety of specific genetic alterations that impact signaling pathway dependencies and therapeutic outcomes. Among the recurrently mutated genes, we identified RHOA , a member of the small GTPase family, as a selective dependency in DLBCL. Here, we show that RHOA function is essential for the survival of ABC DLBCL cells because it sustains oncogenic B cell receptor (BCR) signaling through maintaining a signaling-permissive conformation of the cortical actin network. This enables the formation of active BCR microclusters at the cell surface, ultimately resulting in constitutive, BCR-driven NF-κB survival signaling. Moreover, we found that RHOA controlled endocytosis of the BCR and thereby the assembly of the endolysosomal My–T–BCR multiprotein complex, a central activator of NF-κB consisting of MYD88, Toll-like receptor 9, and the internalized BCR. The recurrent DLBCL-associated RHOA R5W mutation rendered RHOA constitutively active in its GTP-bound state and changed the conformation of the actin network from primarily filamentous actin to globular actin. This altered actin state led to an increase in BCR microcluster formation, amplification of NF-κB signaling, and resistance to inhibitors targeting chronic active BCR signaling. Hence, our study establishes RHOA and its mutant isoforms as critical regulators of oncogenic BCR signaling in DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

rhoA GTP-Binding ProteinSignal TransductionReceptors, Antigen, B-CellLymphoma, Large B-Cell, DiffuseHumansNF-kappa BCell Line, TumorActinsEndocytosisMutationAnimals

Stichwörter der Autor:innen

B cell receptorDLBCLRHOAcytoskeletonlymphoma

Substanzen

rhoA GTP-Binding ProteinReceptors, Antigen, B-CellNF-kappa BRHOA protein, humanActins

Autor:innen und Institutionen

  • Department of Medicine 2, Hematology/Oncology, University Medical Center Frankfurt, Goethe University, Frankfurt am Main 60590, Germany.
  • Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
  • German Cancer Consortium, Partner Site Frankfurt/Mainz and German Cancer Research Center, Heidelberg 60590, Germany.
  • Institute for Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen 37075, Germany.
  • Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
  • Department of Hematology, Oncology and Tumor Immunology, Charité University Medical Center, Berlin 12203, Germany.

Förderung

  • LOEWE Hessen
  • Deutsche Forschungsgemeinschaft (DFG)
  • Else Kröner-Fresenius-Stiftung (EKFS)

Zitieren

APA

Jacobs, A. N., Jahn, D., Beringer, T., Wolf, S., Krishnan, R. K., Engelke, M., Häupl, B., Münch, S., Dienstbier, N., Pape, M., Bodach, M., Yu, X., Serin, N., Wurm-Kuczera, R., Zindel, A., Döbele, C., Chapuy, B., Staudt, L. M., Scheich, S., & Oellerich, T. (2026). RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma. Proceedings of the National Academy of Sciences, 123(5). https://doi.org/10.1073/pnas.2534531123

Vancouver

Jacobs AN, Jahn D, Beringer T, Wolf S, Krishnan RK, Engelke M, et al. RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma. Proceedings of the National Academy of Sciences. 2026;123(5). doi:10.1073/pnas.2534531123

BibTeX
@article{Jacobs2026,
  author = {Jacobs, Ariana N and Jahn, Dominique and Beringer, Tim and Wolf, Sebastian and Krishnan, Ramesh K and Engelke, Michael and Häupl, Björn and Münch, Silvia and Dienstbier, Niklas and Pape, Martine and Bodach, Marion and Yu, Xin and Serin, Nazli and Wurm-Kuczera, Rebecca and Zindel, Alena and Döbele, Carmen and Chapuy, Björn and Staudt, Louis M and Scheich, Sebastian and Oellerich, Thomas},
  title = {RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {5},
  doi = {10.1073/pnas.2534531123}
}
Kostenlos starten →